Anillos aórticos pequeños, ¿Qué válvula deberíamos elegir?

Avatar Trial: Is It Time to Use Surgical Aortic Valve Replacement in Asymptomatic Patients?

It is still unclear whether surgical aortic valve replacement (SAVR) is beneficial in asymptomatic patients with severe aortic stenosis (AS) and conserved left ventricular function (C1 indication according to AHA guidelines). The European American guidelines only recommend intervention in asymptomatic patient when there is ventricular compromise (ejection fraction <50%, class I indication) or with a<a href="https://solaci.org/en/2022/05/05/avatar-trial-is-it-time-to-use-surgical-aortic-valve-replacement-in-asymptomatic-patients/" title="Read more" >...</a>

WOEST 2 | Dual Versus Triple Antithrombotic Scheme in the Real World.

The WOEST study found a significant reduction in bleeding complications post PCI with oral anticoagulation indication (OAC) when treating patients with dual antiplatelet therapy (DAPT) vs. the triple antithrombotic scheme. Several randomized studies have shown these results. At present, the guidelines recommend using the triple antithrombotic scheme in patients according to ischemic and bleeding risk. <a href="https://solaci.org/en/2022/04/22/woest-2-dual-versus-triple-antithrombotic-scheme-in-the-real-world-antiplatelet-therapy-anticoagulation-scheme/" title="Read more" >...</a>

El uso de imágenes intravasculares para guiar la angioplastia reduce el riesgo de muerte cardiovascular en comparación con la angiografía

5-year TVF and MACCE in patients with deferred of revascularization after FFR: Is FFR enough?

Fractional flow reserve (FFR) has been shown effective and safe by different studies, yet not at 5 years.  The aim of this multicenter registry was to assess the impact of thrombotic risk (as per CREDO-Kyoto score) as a predictor of cardiovascular events at 5 years in patients with deferred revascularization after FFR measurement.  The score<a href="https://solaci.org/en/2022/04/13/5-year-tvf-and-macce-in-patients-with-deferred-of-revascularization-after-ffr-is-ffr-enough/" title="Read more" >...</a>

ACC 2022 | IVVE

This randomized study aimed at assessing the flu vaccine vs placebo in patients with cardiac failure.  It included 5129 patients with cardiac failure randomized to receiving the flu vaccine annually for 3 years vs placebo.  Primary end point included cardiovascular death, non-fatal AMI, and stroke. There were no significant differences between both groups. However, pneumonia<a href="https://solaci.org/en/2022/04/08/acc-2022-ivve/" title="Read more" >...</a>

ACC 2022 | PROMPT-HF

Patients with cardiac failure with reduced ejection fraction (HFrEF) are sub treated when you look at guideline-directed medical therapy (GDMT).    The aim of this study was to assess if, using an electronic registry, we can alert treating physicians and optimize medical treatment.   100 healthcare professionals (doctors, nurses, etc) were randomized to receiving and alert<a href="https://solaci.org/en/2022/04/08/acc-2022-prompt-hf/" title="Read more" >...</a>

The Most Read Articles of 2021: COVID-19

A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on COVID-19. Follow us to keep up to date. The Most Read Articles of 2021: COVID-19 01- Efficacy of the Sinopharm Vaccine Against COVID-19 Vaccines developed with two different inactivated strains of SARS-CoV-2 (Sinopharm) significantly reduced<a href="https://solaci.org/en/2021/12/27/the-most-read-articles-of-2021-covid-19/" title="Read more" >...</a>

The Most Read Articles of 2021: Pharmacology

A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on a vital topic, pharmacology. Follow us to keep up to date. The Most Read Articles of 2021: Pharmacology 01- Swan Ganz Associated with Better Outcomes in Cardiogenic Shock: Is It Back? The Swan<a href="https://solaci.org/en/2021/12/24/the-most-read-articles-of-2021-pharmacology/" title="Read more" >...</a>

The Most Read Articles of 2021: Coronary Disease

A new year is coming to an end and at SOLACI we are going over the most read studies on our website, on a vital topic, peripheral vascular disease. Follow us to keep up to date. Most Read Articles on Coronary Disease 01- Post MI Betablockers for Good? Patients receiving optimal medical treatment after MI<a href="https://solaci.org/en/2021/12/24/the-most-read-articles-of-2021-coronary-disease/" title="Read more" >...</a>

AHA 2021 | AVATAR: Early Intervention in Asymptomatic Aortic Stenosis

Early surgical aortic valve replacement (SAVR) in patients with severe asymptomatic aortic stenosis can be beneficial in selected patients vs. waiting for symptoms.  Severe AS in patients with no symptoms and conserved ventricular function raises few questions, clinically speaking. However, there is little evidence in favor of early intervention vs. close observation.  The best data<a href="https://solaci.org/en/2021/11/23/aha-2021-avatar-early-intervention-in-asymptomatic-aortic-stenosis/" title="Read more" >...</a>

TAVR vs Sutureless Surgical Aortic Valve Replacement in Low-Risk Patients

Sutureless surgical aortic valve replacement (SU-SAVR) has been designed to make surgical valve replacement easier and faster, especially compared against conventional biological valves which require multiple sutures; their rapid deployment translates into reduced cross-clamp and operative time. These valves shorten operating time and are less invasive than conventional surgical valves.  Except for sternotomy incisions, they<a href="https://solaci.org/en/2021/11/19/tavr-vs-sutureless-surgical-aortic-valve-replacement-in-low-risk-patients/" title="Read more" >...</a>